Emery Pharma Speaker Series:
I'm delighted to introduce you to Dr. Nasredin Mussa. Dr. Mussa earned his MS and PhD from the University of Surrey in the UK. He underwent management training at Bolden Management Consultant, Boston University, and Columbia University in New York. With over 11 years of experience at Lanza, he served as the head of Analytical Development and Process Analytical. He also held positions as director of Biologics Analytical Development, CMC, at Janssen Pharmaceutical Company, and as head of Development, CMC, Process Analytical at Bristol Myers Squibb. Most recently, he was the vice president at Ultragenics Pharmaceuticals, overseeing CMC and QC. Dr. Moussa has now established his own company, Dynamica Biologics, and Emery Pharma is excited to collaborate with him on developing gene therapy analytical methodologies.
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com/
19 мар 2024
